Concealment and fabrication by experienced research subjects

Clinical Trials

Volumn 10, Issue 6, 2013, Pages 935-948

  Devine, Eric G ^a   Waters, Megan E ^a   Putnam, Megan ^b   Surprise, Caitlin ^a   O'Malley, Katie ^a   Richambault, Courtney ^a   Fishman, Rachel L ^a   Knapp, Clifford M ^a   Patterson, Elissa H ^a   Sarid Segal, Ofra ^a   Streeter, Chris ^a   Colanari, Laurie ^a   Ciraulo, Domenic A ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Fairleigh Dickenson University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RECREATIONAL DRUG;

ADULT; ARTICLE; CLINICAL TRIAL (TOPIC); DECEPTION; FEMALE; HUMAN; MALE; MEDICAL INFORMATION; MEDICAL RESEARCH; PRIORITY JOURNAL; RESEARCH SUBJECT; SELF REPORT;

CLINICAL TRIALS AS TOPIC; DECEPTION; FEMALE; HUMANS; INCOME; MALE; MIDDLE AGED; MOTIVATION; PATIENT SELECTION; RESEARCH SUBJECTS; SELF REPORT; SEX FACTORS; UNEMPLOYMENT;

EID: 84889808445     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774513492917     Document Type: Article

References (14)

1. Waldman M. London's disastrous drug trial has serious side effects for research. Nature. 2006 ; 440: 388-89
2. Fry C, Dwyer R. For love or money? An exploratory study of why injecting drug users participate in research. Addiction. 2001 ; 96: 1319-25
3. Abadie R The professional guinea pig: Big Pharma and the risky world of human subjects. Durham, NC: Duke University Press ; 2010:
4. Randolph AG. The unique challenges of enrolling patients into multiple clinical trials. Crit Care Med. 2009 ; 37: S107-11
5. Tishler C, Bartholomae S. Repeat participation among normal healthy research volunteers: Professional guinea pigs in clinical trials?. Perspect Biol Med. 2003 ; 46: 508-20
6. Boyar D, Goldfarb NM. Preventing overlapping enrollment in clinical studies. J Clin Res Best Pract. 2010 ; 6: 1-4
7. Apseloff G, Swayne JK, Gerber N. Medical histories may be unreliable in screening volunteers for clinical trials. Clin Pharmacol Ther. 1996 ; 60: 353-56
8. Macklin R. On paying money to research subjects: 'due' and 'undue' inducements. IRB. 1981 ; 3: 1-6
9. Bentley J, Thacker P. The influence of risk and monetary payment on the research participation decision making process. J Med Ethics. 2004 ; 30: 293-98
10. Risch SC, Lewine RJ, Jewart RD, et al. Ensuring the normalcy of 'normal' volunteers. Am J Psychiatry. 1990 ; 147: 682-83
11. Apseloff G, Ashton HM, Friedman H, et al. The importance of measuring cotinine levels to identify smokers in clinical trials. Clin Pharmacol Ther. 1994 ; 56: 460-62
12. Hermann R, Heger-Mahn D, Mahler M, et al. Adverse events and discomfort in studies on healthy subjects: The volunteer's perspective. Eur J Clin Pharmacol. 1997 ; 53: 207-14
13. Resnik DB, Koski G. A national registry for healthy volunteers in phase 1 clinical trials. JAMA. 2011 ; 305: 1236-37
14. Grady C. Payment of clinical research subjects. J Clin Invest. 2005 ; 115: 1681-87